Bayer's Nexavar has had the first-line liver cancer space to itself for years, but Eisai is doing its best to change that.
The FDA actually invited Mitsubishi Tanabe to file Radicava for U.S. approval based on data generated in Japan. Now, it's the first new ALS med in decades.
Two months after snapping up Ariad, Takeda is getting a quick return. The Ariad-developed potential blockbuster Alunbrig won FDA approval Friday.
What could China's newly proposed foreign drug policy mean for multinational pharma companies, and how will it change the world’s second-largest pharma…
Johnson & Johnson has kept a positive attitude about its blockbuster immunology drug Remicade and the biosimilar competition it’s facing.
Takeda has finished enrolling 20,100 children for a massive phase 3 dengue vaccine study.
A rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial.
The CDC is preparing a new avian influenza vaccine candidate amid an outbreak in China.
China’s BeiGene, which is developing a portfolio of immuno-oncology drugs, has struck a deal with a Chinese development agency to build a biologics plant to…
Takeda has partnered with digital health tools venture Cognition Kit to collect active and passive patient data for a deep dive on depression.